Adam Stenman

About me
Publications
CV
Public outreach and news

About me

Associate professor at Karolinska Institutet (MMK) and Surgeon at the Endocrine Surgery department at Karolinska University Hospital, Solna (KS).

Research

Our research group in Endocrine Surgery at the Department of Molecular Medicine and Surgery is a multidisciplinary team composed of researchers, postdocs, and PhD students with clinical affiliations, all focused on endocrine tumors. We engage in entirely translational research, where issues identified within healthcare drive pre-clinical research and development. Our goal is to transfer the findings into tangible patient benefits - specifically, improved diagnostic, prognostic, and treatment methods. Through close collaboration between surgery, pathology, genetics, and omics, we strive to address clinical questions with technology rooted in fundamental research.

Articles

Article: ENDOCRINE PATHOLOGY. 2024;:1-8
Catching the Silent Culprits: TERT Promoter Mutation Screening of Minimally Invasive Follicular and Oncocytic Thyroid Carcinoma in Clinical Practice
Hellgren LS; Stenman A; Jatta K; Condello V; Larsson C; Zedenius J; Juhlin CC
Article: ENDOCRINE-RELATED CANCER. 2024;31(9):e230061
Genetic variants and down-regulation of CACNA1H in pheochromocytoma.
Svahn F; Solhusløkk Höse K; Stenman A; Liu Y; Calissendorff J; Tham E; Végvári Á; Zubarev RA; Wang N; Korah R; Carling T; Zedenius J; Bränström R; Juhlin CC; Larsson C
Article: ENDOCRINE. 2024;85(1):356-362
Adrenal tumors in patients with neuroendocrine neoplasms
Falhammar H; Stenman A; Juhlin CC; Kistner A
Article: VIRCHOWS ARCHIV. 2024;485(1):105-114
Atrophic changes in thyroid tumors are strong indicators of underlying DICER1 mutations: a bi-institutional genotype-phenotype correlation study
Condello V; Roberts JW; Stenman A; Larsson C; Viswanathan K; Juhlin CC
Journal article: ENDOCRINE ABSTRACTS. 2024
Catching the silent culprits: Prospective TERT promoter mutation screening for minimally invasive follicular and oncocytic thyroid carcinoma in clinical practice
Hellgren LS; Stenman A; Larsson C; Zedenius J; Juhlin CC
Journal article: ENDOCRINE ABSTRACTS. 2024
The presence of abortive changes in thyroid tumors serves as a strong indicator of underlying DICER1 mutations
Condello V; Roberts J; Stenman A; Larsson C; Viswanathan K; Juhlin C
Article: ENDOCRINE. 2023;82(3):631-637
Adrenal and periadrenal schwannoma: histological, molecular and clinical characterization of an institutional case series
Stenman A; Falhammar H; Zedenius J; Juhlin CC
Article: DIAGNOSTIC CYTOPATHOLOGY. 2023;51(6):331-340
Digital droplet PCR TERT promoter mutational screening in fine needle aspiration cytology of thyroid lesions: A highly specific technique for pre-operative identification of high-risk cases
Hysek M; Hellgren LS; Stenman A; Darai-Ramqvist E; Ljung E; Schliemann I; Condello V; Larsson C; Zedenius J; Jatta K; Juhlin CC
Article: EUROPEAN JOURNAL OF ENDOCRINOLOGY (EJE). 2023;188(4):K11-K16
Immunohistochemical characterization of a steroid-secreting oncocytic adrenal carcinoma responsible for paraneoplastic hyperparathyroidism
Haissaguerre M; Louiset E; Juhlin CC; Stenman A; Laurent C; Trouette H; Lefebvre H; Tabarin A
Article: ENDOCRINE PATHOLOGY. 2023;34(1):129-141
TOP2A Expression in Pheochromocytoma and Abdominal Paraganglioma: a Marker of Poor Clinical Outcome?
Hose KS; Stenman A; Svahn F; Larsson C; Juhlin CC
Article: ENDOCRINE PATHOLOGY. 2022;33(4):525-527
Papillary Thyroid Carcinoma with Desmoid-Like Fibromatosis: Double Trouble?
Juhlin CC; Hysek M; Stenman A; Zedenius J
Journal article: HUMAN PATHOLOGY REPORTS. 2022;29:300656
Adrenal cortical adenoma arising in an adreno-hepatic fusion: Case report and literature review of a potential diagnostic pitfall
Stenman A; Shabo I; Zedenius J; Juhlin CC
Article: ENDOCRINE PATHOLOGY. 2022;33(2):231-242
Prognostic Utility of the Ki-67 Labeling Index in Follicular Thyroid Tumors: a 20-Year Experience from a Tertiary Thyroid Center
Hellgren LS; Stenman A; Paulsson JO; Hoog A; Larsson C; Zedenius J; Juhlin CC
Article: THYROID RESEARCH. 2022;15(1):5
Seasonal variation in calcium treatment after thyroidectomy as surrogate for post-operative hypocalcemia: a retrospective register-based national cohort study
Kordel C; Koman A; Branstrom R; Stenman A
Article: THYROID RESEARCH. 2022;15(1):1
Synchronous lateral lymph node metastases from papillary and follicular thyroid carcinoma: case report and review of the literature
Stenman A; Kjellman M; Zedenius J; Juhlin CC
Article: CANCERS. 2021;13(24):6340
Pan-Genomic Sequencing Reveals Actionable CDKN2A/2B Deletions and Kataegis in Anaplastic Thyroid Carcinoma
Stenman A; Yang M; Paulsson JO; Zedenius J; Paulsson K; Juhlin CC
Journal article: HISTOPATHOLOGY. 2021;79(4):0i
Cover Image
Article: HISTOPATHOLOGY. 2021;79(4):661-666
Macrofollicular variant follicular thyroid tumors are DICER1 mutated and exhibit distinct histological features
Juhlin CC; Stenman A; Zedenius J
Article: THYROID RESEARCH. 2021;14(1):19
Development of metastatic poorly differentiated thyroid cancer from a sub-centimeter papillary thyroid carcinoma in a young patient with a germline MET mutation - association or random chance?
Johansson K; Stenman A; Paulsson JO; Wang N; Ihre-Lundgren C; Zedenius J; Juhlin CC
Article: JOURNAL OF CLINICAL PATHOLOGY. 2021;75(10):jclinpath-2021-207631-662
Nuclear-specific accumulation of telomerase reverse transcriptase (TERT) mRNA in TERT promoter mutated follicular thyroid tumours visualised by in situ hybridisation: a possible clinical screening tool?
Hellgren LS; Olsson A; Kaufeldt A; Paulsson JO; Hysek M; Stenman A; Zedenius J; Larsson C; Hoog A; Juhlin CC
Article: ENDOCRINE-RELATED CANCER. 2021;28(5):337-351
Pan-genomic characterization of high-risk pediatric papillary thyroid carcinoma
Stenman A; Backman S; Johansson K; Paulsson JO; Stalberg P; Zedenius J; Juhlin CC
Article: NUCLEIC ACIDS RESEARCH (NAR). 2021;49(5):2509-2521
Aberrant splicing in neuroblastoma generates RNA-fusion transcripts and provides vulnerability to spliceosome inhibitors
Shi Y; Yuan J; Rraklli V; Maxymovitz E; Cipullo M; Liu M; Li S; Westerlund I; Bedoya-Reina OC; Bullova P; Rorbach J; Juhlin CC; Stenman A; Larsson C; Kogner P; O'Sullivan MJ; Schlisio S; Holmberg J
Article: JOURNAL OF MOLECULAR DIAGNOSTICS. 2021;23(2):212-222
Spatial Distribution Patterns of Clinically Relevant TERT Promoter Mutations in Follicular Thyroid Tumors of Uncertain Malignant Potential Advantages of the Digital Droplet PCR Technique
Hysek M; Jatta K; Hellgren LS; Stenman A; Larsson C; Zedenius J; Juhlin CC
Article: MEDICINE (UNITED KINGDOM). 2021;100(2):e24237
Metastatic-prone telomerase reverse transcriptase (TERT) promoter and v-Raf murine sarcoma viral oncogene homolog B (BRAF) mutated tall cell variant of papillary thyroid carcinoma arising in ectopic thyroid tissue A case report
Stenman A; Koman A; Ihre-Lundgren C; Juhlin CC
Article: BRAIN PATHOLOGY. 2021;31(1):61-69
TERTpromoter mutations in primary and secondary WHO grade III meningioma
Maier AD; Stenman A; Svahn F; Mirian C; Bartek JJ; Juhler M; Zedenius J; Broholm H; Mathiesen T
Article: JOURNAL OF THE ENDOCRINE SOCIETY. 2020;4(7):bvaa060
Recurrent Amplification of the Osmotic Stress Transcription Factor NFAT5 in Adrenocortical Carcinoma
Brown TC; Nicolson NG; Man J; Gibson CE; Stenman A; Juhlin CC; Korah R; Carlin T
Article: ENDOCRINE-RELATED CANCER. 2020;27(5):295-308
GABPA-dependent down-regulation of DICER1 in follicular thyroid tumours
Paulsson JO; Wang N; Gao J; Stenman A; Zedenius J; Mu N; Lui W-O; Larsson C; Juhlin CC
Article: ENDOCRINE PATHOLOGY. 2020;31(1):77-83
Metastatic Anaplastic Thyroid Carcinoma in Complete Remission: Morphological, Molecular, and Clinical Work-Up of a Rare Case
Stenman A; Hellgren LS; Jatta K; Hysek M; Zemmler M; Altena R; Nilsson I-L; Branstrom R; Zedenius J; Juhlin CC
Article: JOURNAL OF PATHOLOGY. 2020;250(2):183-194
Whole-genome sequencing of synchronous thyroid carcinomas identifies aberrant DNA repair in thyroid cancer dedifferentiation
Paulsson JO; Backman S; Wang N; Stenman A; Crona J; Thutkawkorapin J; Ghaderi M; Tham E; Stalberg P; Zedenius J; Juhlin CC
Article: DIAGNOSTIC PATHOLOGY. 2019;14(1):127
Signet ring cell variant of follicular thyroid carcinoma: Report of two cases with focus on morphological, expressional and genetic characteristics
Hysek M; Jatta K; Stenman A; Darai-Ramqvist E; Zedenius J; Hoog A; Juhlin CC
Article: SURGERY. 2019;166(5):901-906
Retrospective application of the pathologic tumor-node-metastasis classification system for pheochromocytoma and abdominal paraganglioma in a well characterized cohort with long-term follow-up
Stenman A; Zedenius J; Juhlin CC
Article: CANCERS. 2019;11(10):E1443-1443
Clinical Routine TERT Promoter Mutational Screening of Follicular Thyroid Tumors of Uncertain Malignant Potential (FT-UMPs): A Useful Predictor of Metastatic Disease
Hysek M; Paulsson JO; Jatta K; Shabo I; Stenman A; Hoog A; Larsson C; Zedenius J; Juhlin CC
Article: ENDOCRINE PATHOLOGY. 2019;30(3):246-248
TERT Promoter Mutation Spatial Heterogeneity in a Metastatic Follicular Thyroid Carcinoma: Implications for Clinical Work-Up
Stenman A; Hysek M; Jatta K; Branstrom R; Darai-Ramqvist E; Paulsson JO; Wang N; Larsson C; Zedenius J; Juhlin CC
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2019;116(34):16997-17006
EglN3 hydroxylase stabilizes BIM-EL linking VHL type 2C mutations to pheochromocytoma pathogenesis and chemotherapy resistance
Li S; Rodriguez J; Li W; Bullova P; Fell SM; Surova O; Westerlund I; Topcic D; Bergsland M; Stenman A; Muhr J; Nister M; Holmberg J; Juhlin CC; Larsson C; von Kriegsheim A; Kaelin WGJ; Schlisio S
Article: JOURNAL OF THE ENDOCRINE SOCIETY. 2019;3(8):1518-1530
Presentation, Treatment, Histology, and Outcomes in Adrenal Medullary Hyperplasia Compared With Pheochromocytoma
Falhammar H; Stenman A; Calissendorff J; Juhlin CC
Article: MODERN PATHOLOGY. 2019;32(8):1082-1094
Parafibromin immunostainings of parathyroid tumors in clinical routine: a near-decade experience from a tertiary center
Juhlin CC; Nilsson I-L; Lagerstedt-Robinson K; Stenman A; Branstrom R; Tham E; Hoog A
Article: LAKARTIDNINGEN. 2019;116:FHM3
[Endocrine tumours in Stockholm - increasing general incidence].
Juhlin CC; Stenman A; Zedenius J
Article: AMERICAN JOURNAL OF SURGICAL PATHOLOGY. 2019;43(3):409-421
Molecular Profiling of Pheochromocytoma and Abdominal Paraganglioma Stratified by the PASS Algorithm Reveals Chromogranin B as Associated With Histologic Prediction of Malignant Behavior
Stenman A; Svahn F; Hojjat-Farsangi M; Zedenius J; Soderkvist P; Gimm O; Larsson C; Juhlin CC
Article: ONCOGENE. 2019;38(7):965-979
GABPA inhibits invasion/metastasis in papillary thyroid carcinoma by regulating DICER1 expression
Yuan X; Mu N; Wang N; Straat K; Sofiadis A; Guo Y; Stenman A; Li K; Cheng G; Zhang L; Kong F; Ekblad L; Wennerberg J; Nilsson I-L; Juhlin CC; Larsson C; Xu D
Article: INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE. 2018;42(3):1675-1683
TERT promoter hypermethylation is associated with poor prognosis in adrenocortical carcinoma
Svahn F; Paulsson JO; Stenman A; Fotouhi O; Mu N; Murtha TD; Korah R; Carling T; Baeckdahl M; Wang N; Juhlin CC; Larsson C
Article: LANGENBECK'S ARCHIVES OF SURGERY. 2018;403(6):785-790
Over-diagnosis of potential malignant behavior in MEN 2A-associated pheochromocytomas using the PASS and GAPP algorithms
Stenman A; Zedenius J; Juhlin CC
Article: ACTA PAEDIATRICA, INTERNATIONAL JOURNAL OF PAEDIATRICS. 2018;107(1):126-133
Sex and maturity status affected the validity of a submaximal cycle test inadolescents
Bjorkman F; Eggers A; Stenman A; Bohman T; Ekblom B; Ekblom O
Article: JAMA ONCOLOGY. 2017;3(9):1204-1212
Clinical Characterization of the Pheochromocytoma and Paraganglioma Susceptibility Genes SDHA, TMEM127, MAX, and SDHAF2 for Gene-Informed Prevention
Bausch B; Schiavi F; Ni Y; Welander J; Patocs A; Ngeow J; Wellner U; Malinoc A; Taschin E; Barbon G; Lanza V; Soederkvist P; Stenman A; Larsson C; Svahn F; Chen J-L; Marquard J; Fraenkel M; Walter MA; Peczkowska M; Prejbisz A; Jarzab B; Hasse-Lazar K; Petersenn S; Moeller LC; Meyer A; Reisch N; Trupka A; Brase C; Galiano M; Preuss SF; Kwok P; Lendvai N; Berisha G; Makay O; Boedeker CC; Weryha G; Racz K; Januszewicz A; Walz MK; Gimm O; Opocher G; Eng C; Neumann HPH
Article: HORMONE AND METABOLIC RESEARCH. 2017;49(8):631-637
Suppression of Forkhead Box Protein O1 (FOXO1) Transcription Factor May Promote Adrenocortical Tumorigenesis
Stenman A; Murtha T; Korah R; Carling T
Article: BMC CANCER. 2017;17(1):164
A novel FOXO1-mediated dedifferentiation blocking role for DKK3 in adrenocortical carcinogenesis
Cheng JY; Brown TC; Murtha TD; Stenman A; Juhlin CC; Larsson C; Healy JM; Prasad ML; Knoefel WT; Krieg A; Scholl UI; Korah R; Carling T
Article: GENES CHROMOSOMES AND CANCER. 2016;55(5):452-459
HRAS mutation prevalence and associated expression patterns in pheochromocytoma
Stenman A; Welander J; Gustavsson I; Brunaud L; Backdahl M; Soderkvist P; Gimm O; Juhlin CC; Larsson C
Article: PLOS ONE. 2016;11(9):e0162379
Human Cytochrome P450 2W1 Is Not Expressed in Adrenal Cortex and Is Only Rarely Expressed in Adrenocortical Carcinomas
Nole P; Duijndam B; Stenman A; Juhlin CC; Kozyra M; Larsson C; Ingelman-Sundberg M; Johansson I
Article: SURGERY. 2016;159(1):250-257
DNA copy amplification and overexpression of SLC12A7 in adrenocortical carcinoma
Brown TC; Juhlin CC; Healy JM; Stenman A; Rubinstein JC; Korah R; Carling T
Article: SURGERY. 2016;159(1):296-301
Chromosome 19 amplification correlates with advanced disease in adrenocortical carcinoma
Rubinstein JC; Brown TC; Goh G; Juhlin CC; Stenman A; Korah R; Carling T
Article: GENES CHROMOSOMES AND CANCER. 2015;54(9):542-554
Whole-exome sequencing defines the mutational landscape of pheochromocytoma and identifies KMT2D as a recurrently mutated gene
Juhlin CC; Stenman A; Haglund F; Clark VE; Brown TC; Baranoski J; Bilguvar K; Goh G; Welander J; Svahn F; Rubinstein JC; Caramuta S; Yasuno K; Guenel M; Backdahl M; Gimm O; Soderkvist P; Prasad ML; Korah R; Lifton RP; Carling T
Article: HUMAN MOLECULAR GENETICS. 2015;24(8):2318-2329
Characterization of the mutational landscape of anaplastic thyroid cancer via whole-exome sequencing
Kunstman JW; Juhlin CC; Goh G; Brown TC; Stenman A; Healy JM; Rubinstein JC; Choi M; Kiss N; Nelson-Williams C; Mane S; Rimm DL; Prasad ML; Hoog A; Zedenius J; Larsson C; Korah R; Lifton RP; Carling T
Article: ENDOCRINE PATHOLOGY. 2015;26(1):9-14
Immunohistochemical NF1 Analysis Does not Predict NF1 Gene Mutation Status in Pheochromocytoma
Stenman A; Svahn F; Welander J; Gustavson B; Soderkvist P; Gimm O; Juhlin CC
Article: JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM (JCEM). 2015;100(3):E493-E502
Whole-Exome Sequencing Characterizes the Landscape of Somatic Mutations and Copy Number Alterations in Adrenocortical Carcinoma
Juhlin CC; Goh G; Healy JM; Fonseca AL; Scholl UI; Stenman A; Kunstman JW; Brown TC; Overton JD; Mane SM; Nelson-Williams C; Backdahl M; Suttorp A-C; Haase M; Choi M; Schlessinger J; Rimm DL; Hoog A; Prasad ML; Korah R; Larsson C; Lifton RP; Carling T
Article: JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM (JCEM). 2014;99(7):E1352-E1360
Rare Germline Mutations Identified by Targeted Next-Generation Sequencing of Susceptibility Genes in Pheochromocytoma and Paraganglioma
Welander J; Andreasson A; Juhlin CC; Wiseman RW; Backdahl M; Hoog A; Larsson C; Gimm O; Soderkvist P
Article: ENDOCRINE-RELATED CANCER. 2014;21(3):427-434
The activating TERT promoter mutation C228T is recurrent in subsets of adrenal tumors
Liu T; Brown TC; Juhlin CC; Andreasson A; Wang N; Backdahl M; Healy JM; Prasad ML; Korah R; Carling T; Xu D; Larsson C
Article: ENDOCRINE-RELATED CANCER. 2014;21(3):495-504
Frequent EPAS1/HIF2α exons 9 and 12 mutations in non-familial pheochromocytoma
Welander J; Andreasson A; Brauckhoff M; Backdahl M; Larsson C; Gimm O; Soderkvist P
Article: LAKARTIDNINGEN. 2014;111(8):340-341
[Pheochromocytoma can easily be missed in an unusual symptomatology. Hypotension and syncope were interpreted as orthostatism].
Fridegren J; Andreasson A; Wallin C
Article: BIOPRESERVATION AND BIOBANKING. 2013;11(6):366-370
Long-Term Storage of Endocrine Tissues at-80°C Does Not Adversely Affect RNA Quality or Overall Histomorphology
Andreasson A; Kiss NB; Juhlin CC; Hoog A
Article: EPIGENETICS. 2013;8(12):1347-1354
The VHL gene is epigenetically inactivated in pheochromocytomas and abdominal paragangliomas
Andreasson A; Kiss NB; Caramuta S; Sulaiman L; Svahn F; Backdahl M; Hoog A; Juhlin CC; Larsson C
Article: ENDOCRINE-RELATED CANCER. 2013;20(1):65-78
Acquired hypermethylation of the P16^INK4A promoter in abdominal paraganglioma: relation to adverse tumor phenotype and predisposing mutation
Kiss NB; Muth A; Andreasson A; Juhlin CC; Geli J; Backdahl M; Hoog A; Wangberg B; Nilsson O; Ahlman H; Larsson C
Article: FAMILIAL CANCER. 2012;11(3):355-362
Molecular characterization of parathyroid tumors from two patients with hereditary colorectal cancer syndromes
Andreasson A; Sulaiman L; do Vale S; Martins JM; Ferreira F; Miltenberger-Miltenyi G; Batista L; Haglund F; Bjorck E; Nilsson I-L; Hoog A; Larsson C; Juhlin CC
Article: PLOS ONE. 2012;7(5):e36448
Prolactin Receptor in Primary Hyperparathyroidism - Expression, Functionality and Clinical Correlations
Haglund F; Lu M; Vukojevic V; Nilsson I-L; Andreasson A; Dzabic M; Branstrom R; Hoog A; Juhlin CC; Larsson C
Show more

All other publications

Editorial comment: CANCERS. 2023;15(18):4621
Novel Insights in the Genomics of Anaplastic Thyroid Carcinoma: A Role for Cyclin-Dependent Kinase Inhibition?
Stenman A; Juhlin CC
Review: LAKARTIDNINGEN. 2023;120:23014
[Adrenohepatic fusion - an unknown but not uncommon phenomenon of clinical importance].
Stenman A; Zedenius J; Christofer Juhlin C
Conference publication: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2023;50(SUPPL 1):S116
Towards clinical translation of a novel antibody-based ¹⁷⁷Lu-labeled radiopharmaceutical for treatment of anaplastic thyroid cancer
Mortensen A; Berglund H; Shojai TM; Persson HL; Stenman A; Jha P; Juhlin C; Bernhardt P; Zedenius J; Frejd F; Nestor M
Preprint: RESEARCH SQUARE. 2022
TOP2A expression in pheochromocytoma and abdominal paraganglioma: a novel marker of poor clinical outcome?
Höse KS; Stenman A; Svahn F; Larsson C; Juhlin CC
Conference publication: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2022;49(SUPPL 1):S440-S441
Preclinical evaluation of a promising novel, antibody-based ¹⁷⁷Lu-labeled radiopharmaceutical for potential use in advanced thyroid cancer
Mortensen A; Berglund H; Juhlin C; Stenman A; Jha P; Frejd F; Zedenius J; Nestor M
Preprint: BIORXIV. 2019
Alternative splicing in neuroblastoma generates RNA-fusion transcripts and is associated with vulnerability to spliceosome inhibitors
Shi Y; Rraklli V; Maxymovitz E; Li S; Westerlund I; Bedoya-Reina OC; Yuan J; Bullova P; Juhlin CC; Stenman A; Larsson C; Kogner P; O’Sullivan MJ; Schlisio S; Holmberg J
Published conference paper: JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS. 2019;229(3):305-315
Insulin-Like Growth Factor and SLC12A7 Dysregulation: A Novel Signaling Hallmark of Non-Functional Adrenocortical Carcinoma
Brown TC; Nicolson NG; Stenman A; Juhlin CC; Gibson CE; Callender GG; Korah R; Carling T
Review: CANCERS. 2019;11(2):E225-225
The Value of Histological Algorithms to Predict the Malignancy Potential of Pheochromocytomas and Abdominal Paragangliomas-A Meta-Analysis and Systematic Review of the Literature
Stenman A; Zedenius J; Juhlin CC
Other: SAGE OPEN MEDICAL CASE REPORTS. 2019;7:2050313X19883770
Synchronous aldosterone- and cortisol-producing adrenocortical adenomas diagnosed using CYP11B immunohistochemistry
Stenman A; Shabo I; Ramstrom A; Zedenius J; Juhlin CC
Letter: CLINICAL ENDOCRINOLOGY. 2018;88(2):343-345
Telomerase reverse transcriptase promoter hypermethylation is associated with metastatic disease in abdominal paraganglioma
Svahn F; Juhlin CC; Paulsson JO; Fotouhi O; Zedenius J; Larsson C; Stenman A
Editorial comment: JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION. 2016;39(6):715-716
Absence of the BRAF V600E mutation in pheochromocytoma
Paulsson JO; Svahn F; Welander J; Brunaud L; Soderkvist P; Gimm O; Stenman A; Juhlin CC
Letter: CLINICAL ENDOCRINOLOGY. 2016;84(4):632-634
Absence of KMT2D/MLL2 mutations in abdominal paraganglioma
Bilguvar K; Goh G; Korah R; Lifton RP; Carling T
Thesis / dissertation: 2015
Genetic and molecular background of pheochromocytoma and paraganglioma
Stenman, Adam
Letter: ENDOCRINE-RELATED CANCER. 2015;22(3):L9-L11
TERT promoter mutations are rare in parathyroid tumors
Haglund F; Juhlin CC; Brown T; Ghaderi M; Liu T; Stenman A; Dinets A; Prasad M; Korah R; Xu D; Carling T; Larsson C
Letter: CLINICAL ENDOCRINOLOGY. 2010;73(4):552-553
Lack of S37A CTNNB1/β-catenin mutations in a Swedish cohort of 98 parathyroid adenomas
Haglund F; Andreasson A; Nilsson I-L; Hoog A; Larsson C; Juhlin CC

Employments

Affiliated to Research, Department of Molecular Medicine and Surgery, Karolinska Institutet, 2022-2025

Degrees and Education

Docent, Surgery, Karolinska Institutet, 2024
Degree Of Doctor Of Philosophy, Department of Oncology-Pathology, Karolinska Institutet, 2016
Degree Of Master Of Science In Medicine, Karolinska Institutet, 2012

About me

Research

Articles

All other publications

Employments

Degrees and Education

News from KI

Events from KI